Heart procedure may offer stroke prevention for patients who Can't take blood thinners

NCT ID NCT03111654

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a procedure to close the left atrial appendage—a small pouch in the heart where clots often form—in 58 patients with atrial fibrillation who had a prior brain bleed and cannot take standard blood thinners. The goal was to see if this approach could reduce the risk of future strokes and other vascular events. Researchers tracked outcomes like stroke, bleeding, and functional status over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
percutaneous left atrial appendage closure (a procedure to seal off a small pouch in the heart)
What this could lead to
If successful, this approach could offer a safe way to prevent strokes in people with atrial fibrillation who cannot use standard blood thinners because of a past brain bleed.
What could go wrong
This is a small pilot study with only 58 participants and no comparison group, so results may not apply broadly. The procedure itself carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens Picardie

    Amiens, Picardie, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.